Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeanne M Lusher

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Medgenmed : Medscape General Medicine|December 6, 2002
Highlights from the XXV International Congress of the World Federation of Hemophilia. May 19-24, 2002, Seville, SpainJeanne M Lusher,
Seminars in Thrombosis and Hemostasis|July 5, 2002
First and second generation recombinant factor VIII concentrates in previously untreated patients: recovery, safety, efficacy, and inhibitor developmentJeanne M Lusher
Seminars in Hematology|January 24, 2006
Milestones in hemophilia and concepts in future clinical trial designJeanne M Lusher
Blood|January 18, 2014
A longer acting rFVIII, safe and effectiveJeanne M Lusher
International Journal of Hematology|November 3, 2009
Evolution of recombinant factor VIII safety: KOGENATE and Kogenate FS/BayerJeanne M Lusher, Inge Scharrer
Postgraduate Medical Journal|March 9, 2007
How do you treat bleeding disorders with desmopressin?Bülent Ozgönenel, Madhvi Rajpurkar, Jeanne M Lusher
Journal of Pediatric Hematology/Oncology|January 19, 2007
Pediatric reference values for molecular markers in hemostasisDarintr Sosothikul, Panya Seksarn, Jeanne M Lusher
Hematology. American Society of Hematology. Education Program|November 10, 2001
Congenital Hemorrhagic Disorders: New Insights into the Pathophysiology and Treatment of HemophiliaUlla Hedner, David Ginsburg, Jeanne M. Lusher, et al.
Pediatric Blood & Cancer|November 30, 2012
Emergency department visits in children with hemophiliaBülent Özgönenel, Ayesha Zia, Michael U Callaghan, et al.
British Journal of Haematology|May 22, 2008
Thromboelastography in children with coagulation factor deficienciesMeera Chitlur, Indira Warrier, Madhvi Rajpurkar, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Medgenmed : Medscape General Medicine|December 6, 2002
Highlights from the XXV International Congress of the World Federation of Hemophilia. May 19-24, 2002, Seville, SpainJeanne M Lusher,
Seminars in Thrombosis and Hemostasis|July 5, 2002
First and second generation recombinant factor VIII concentrates in previously untreated patients: recovery, safety, efficacy, and inhibitor developmentJeanne M Lusher
Seminars in Hematology|January 24, 2006
Milestones in hemophilia and concepts in future clinical trial designJeanne M Lusher
Blood|January 18, 2014
A longer acting rFVIII, safe and effectiveJeanne M Lusher
International Journal of Hematology|November 3, 2009
Evolution of recombinant factor VIII safety: KOGENATE and Kogenate FS/BayerJeanne M Lusher, Inge Scharrer
Postgraduate Medical Journal|March 9, 2007
How do you treat bleeding disorders with desmopressin?Bülent Ozgönenel, Madhvi Rajpurkar, Jeanne M Lusher
Journal of Pediatric Hematology/Oncology|January 19, 2007
Pediatric reference values for molecular markers in hemostasisDarintr Sosothikul, Panya Seksarn, Jeanne M Lusher
Hematology. American Society of Hematology. Education Program|November 10, 2001
Congenital Hemorrhagic Disorders: New Insights into the Pathophysiology and Treatment of HemophiliaUlla Hedner, David Ginsburg, Jeanne M. Lusher, et al.
Pediatric Blood & Cancer|November 30, 2012
Emergency department visits in children with hemophiliaBülent Özgönenel, Ayesha Zia, Michael U Callaghan, et al.
British Journal of Haematology|May 22, 2008
Thromboelastography in children with coagulation factor deficienciesMeera Chitlur, Indira Warrier, Madhvi Rajpurkar, et al.
Pageof 3